Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
01 1Farmhispania, S.A.
02 1Curia Italy S.r.l.
01 1ATRACURIUM BESYLATE
02 1Atracurium Besylate
01 1Spain
02 1U.S.A
Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
NDC Package Code : 17404-0008
Start Marketing Date : 1996-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55486-1597
Start Marketing Date : 2012-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
A Atracurium Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atracurium Besylate, including repackagers and relabelers. The FDA regulates Atracurium Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atracurium Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atracurium Besylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atracurium Besylate supplier is an individual or a company that provides Atracurium Besylate active pharmaceutical ingredient (API) or Atracurium Besylate finished formulations upon request. The Atracurium Besylate suppliers may include Atracurium Besylate API manufacturers, exporters, distributors and traders.
click here to find a list of Atracurium Besylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atracurium Besylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atracurium Besylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atracurium Besylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atracurium Besylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atracurium Besylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atracurium Besylate suppliers with NDC on PharmaCompass.
We have 2 companies offering Atracurium Besylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
